AbbVie: Solid Play for Long-Term Portfolio episode artwork

EPISODE · May 12, 2026 · 1 MIN

AbbVie: Solid Play for Long-Term Portfolio

from The Daily News Now! Business

AbbVie, a healthcare giant spun off from Abbott Labs, boasts twelve billion-dollar products and a robust pipeline with ninety treatments in development. Its a reliable dividend stock with a 3.4% yield, having increased payouts by over 330% since the spin-off. Valuation is reasonable, with a forward P/E ratio of 14, and revenue growth of 12.4% in Q1. AbbVie is a strong long-term play for investors seeking growth and income in the healthcare sector. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/54dec8f313c1202f

NOW PLAYING

AbbVie: Solid Play for Long-Term Portfolio

0:00 1:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 12, 2026.

What is this episode about?

AbbVie, a healthcare giant spun off from Abbott Labs, boasts twelve billion-dollar products and a robust pipeline with ninety treatments in development. Its a reliable dividend stock with a 3.4% yield, having increased payouts by over 330%...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!